Table 1 Patient characteristics
From: Long-term costs of colorectal cancer treatment in Spain
Colon | Rectum | Total | |
|---|---|---|---|
N | 512 | 187 | 699 |
Age (years) | |||
Mean | 70.4 | 70.5 | 70.5 |
Median | 73.0 | 72.0 | 73.0 |
Sex (%) | |||
Male | 53.9 | 59.4 | 55.4 |
Female | 46.1 | 40.6 | 44.6 |
Year of diagnosis (%) | |||
2000 | 13.3 | 12.3 | 13.0 |
2001 | 14.3 | 15.5 | 14.6 |
2002 | 15.0 | 14.4 | 14.9 |
2003 | 17.0 | 13.4 | 16.0 |
2004 | 17.0 | 13.9 | 16.2 |
2005 | 11.5 | 12.8 | 11.9 |
2006 | 11.9 | 17.6 | 13.4 |
TNM Stage (%) | |||
In situ | 6.6 | 3.2 | 5.7 |
I | 11.7 | 14.4 | 12.5 |
II | 25.8 | 25.1 | 25.6 |
III | 23.2 | 29.4 | 24.9 |
IV | 21.3 | 18.7 | 20.6 |
Unknown | 11.3 | 9.1 | 10.7 |
Surgery (%) | |||
Patients | 68.9 | 75.4 | 70.7 |
Surgical procedure | |||
Right hemicolectomy | 27.7 | 1.1 | 18.6 |
Left hemicolectomy | 5.5 | 0.7 | 3.8 |
Sigmoidectomy | 18.9 | 1.1 | 12.8 |
Other colon resections | 9.2 | 2.2 | 6.8 |
Anterior resection of rectum | 3.9 | 27.7 | 12.1 |
Abdominoperineal resection | 0.0 | 14.2 | 4.9 |
Other rectal resections | 0.8 | 10.9 | 4.2 |
Liver metastases resection | 3.5 | 3.4 | 3.5 |
Other metastases resection | 1.8 | 2.2 | 1.9 |
Other procedures | 28.8 | 36.3 | 31.4 |
Chemotherapy (%) | |||
Patients | 30.1 | 47.1 | 34.6 |
Intention | |||
Neoadjuvant | 1.4 | 27.7 | 11.0 |
Adjuvant | 29.0 | 26.2 | 28.0 |
Advanced disease - Palliative | 63.7 | 44.1 | 56.6 |
Unknown | 5.9 | 2.0 | 4.5 |
Treatment scheme | |||
Fluorouracil +/− Levamisole | 20.0 | 43.9 | 28.5 |
Capecitabine +/− Irinotecan/Oxaliplatin | 23.8 | 16.6 | 21.3 |
Irinotecan - Fluorouracil +/− Leucovorin | 14.7 | 17.1 | 15.6 |
Oxaliplatin - Fluorouracil +/− Leucovorin | 12.1 | 7.5 | 10.4 |
Cetuximab - Irinotecan | 10.3 | 3.2 | 7.8 |
Others | 19.1 | 11.8 | 16.5 |
Radiotherapy (%) | |||
Patients | 7.2 | 48.7 | 18.3 |
Intention | |||
Radical | 39.5 | 74.5 | 64.4 |
Palliative | 60.5 | 25.5 | 35.6 |